XML 31 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Percentage of Net Product Sales and Accounts Receivable Balance

The following table includes the percentage of net product sales and accounts receivable balances for our three major Customers, each of which comprised 10% or more of our net product sales:

 

 

 

Net Product Sales

 

 

Accounts

Receivable

 

 

 

Three Months Ended

June 30, 2022

 

 

Six Months Ended

June 30, 2022

 

 

As of

June 30, 2022

 

Customer A

 

 

42.0

%

 

 

43.4

%

 

 

51.1

%

Customer B

 

 

36.8

%

 

 

36.1

%

 

 

31.3

%

Customer C

 

 

20.0

%

 

 

19.2

%

 

 

16.4

%

Total

 

 

98.8

%

 

 

98.7

%

 

 

98.8

%

Summary of Disaggregated Net Product Sales

The following table provides disaggregated net product sales (in thousands):

 

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

CINVANTI net product sales

 

$

22,661

 

 

$

19,689

 

 

$

43,004

 

 

$

38,150

 

SUSTOL net product sales

 

 

2,446

 

 

 

2,754

 

 

 

4,508

 

 

 

4,311

 

ZYNRELEF net product sales

 

 

2,523

 

 

 

 

 

 

3,575

 

 

 

 

Total net product sales

 

$

27,630

 

 

$

22,443

 

 

$

51,087

 

 

$

42,461

 

Summary of Activity to Product Returns, Distributor Fees and Discounts, Rebates and Administrative Fees

The following table provides a summary of activity with respect to our product returns, distributor fees and discounts, rebates and administrative fees, which are included in other accrued liabilities on the condensed consolidated balance sheets (in thousands):

 

 

 

Product

Returns

 

 

Distributor

Fees

 

 

Discounts,

Rebates and

Administrative Fees

 

 

Total

 

Balance at December 31, 2021

 

$

2,579

 

 

$

3,466

 

 

$

16,515

 

 

$

22,560

 

Provision

 

 

943

 

 

 

10,137

 

 

 

76,802

 

 

 

87,882

 

Payments/credits

 

 

(549

)

 

 

(8,696

)

 

 

(73,316

)

 

 

(82,561

)

Balance at June 30, 2022

 

$

2,973

 

 

$

4,907

 

 

$

20,001

 

 

$

27,881

 

Common Stock Equivalents Excluded From Computation of Net Loss Per Share

Because we have incurred a net loss for all periods presented in the unaudited condensed consolidated statements of operations and comprehensive loss, the following common stock equivalents were not included in the computation of net loss per share because their effect would be anti-dilutive (in thousands):

 

 

June 30,

 

 

 

2022

 

 

2021

 

Stock options outstanding

 

 

20,371

 

 

 

18,307

 

Restricted stock units outstanding

 

 

2,207

 

 

 

654

 

Warrants outstanding

 

 

 

 

 

25

 

Shares of common stock underlying convertible notes

   outstanding

 

 

9,819

 

 

 

9,819